Filing Details
- Accession Number:
- 0000914190-16-000741
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-17 18:03:11
- Reporting Period:
- 2016-08-15
- Filing Date:
- 2016-08-17
- Accepted Time:
- 2016-08-17 18:03:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1195116 | Arno Therapeutics Inc | ARNI | Pharmaceutical Preparations (2834) | 522286452 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1296549 | Arie Belldegrun | C/O Arno Therapeutics, Inc. 200 Route 31 North, Suite 104 Flemington NJ 08822 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-08-15 | 714,285 | $0.00 | 2,262,838 | No | 4 | P | Indirect | Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | 2016 Series F Warrants (right to buy) | Acquisiton | 2016-08-15 | 357,142 | $0.00 | 357,142 | $0.44 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
357,142 | 2016-08-15 | 2021-08-15 | No | 4 | P | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 3,115 | Direct | |
Common Stock | 858,094 | Indirect | Leumi Overseas Trust Corp. Ltd. as TTEE of the BTL Trust |
Common Stock | 254,887 | Indirect | Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust |
Common Stock | 379,294 | Indirect | Belldegrun Family Trust |
Common Stock | 174,644 | Indirect | MDRB Partnership, L.P. |
Footnotes
- The reported securities are included within 714,285 Issuer units purchased by the Reporting Person for $0.35 per unit. Each unit consists of one share of common stock and a 2016 Series F Warrant to purchase one-half share of common stock.
- The Reporting Person is the trustee of the profit sharing plan that owns the securities.
- Although the Reporting Person is not a trustee of the BTL Trust, the Reporting Person is a beneficiary of the BTL Trust, and as such may be deemed to be the beneficial owner of the securities owned by the BTL Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- Although the Reporting Person is not a trustee of the Tampere Trust, the Reporting Person is a beneficiary of the Tampere Trust, and as such may be deemed to be the beneficial owner of the securities owned by the Tampere Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- The Reporting Person is the trustee of the family trust that owns the securities. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- The Reporting Person is the managing partner of the limited partnership that owns the securities. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.